Abstract
CD8+ T-cell exhaustion is a promising prognostic indicator of sepsis-induced acute respiratory distress syndrome (ARDS). Patients with sepsis-related ARDS had reduced levels of HSP90AA1. However, whether the changes in CD8+ T cells were related to HSP90α, encoded by the HSP90AA1 gene, was unclear. This study aimed to examine the regulatory mechanism of HSP90α and its impact on CD8+ T-cell exhaustion in lipopolysaccharide (LPS)-induced acute lung injury (ALI). In this study, by conducting a mouse model of ALI, we found that one week after LPS-induced ALI, CD8+ T cells showed exhaustion characteristics. At this time, proliferation and cytokine release in CD8+ T cells were reduced. The inhibitory costimulatory factors PD-1 and Tim-3, on the other hand, were enhanced. Meanwhile, the expression of HSP90α and STAT1 decreased significantly. The in vitro studies showed that HSP90α stimulation or inhibition affected the CD8+ T-cell exhaustion phenotype. Interference with STAT1 reduced the expression of HSP90α and impaired its regulation of CD8+ T cells. The Co-Immunoprecipitation results indicated that HSP90α can directly or indirectly bind to TOX to regulate TOX expression and downstream signal transduction. In summary, by inhibiting TOX-mediated exhaustion signaling pathways, HSP90α inhibited CD8+ T-cell exhaustion in ALI. The participation of STAT1 in the regulation of HSP90α was required.
Similar content being viewed by others
Introduction
Sepsis is acute organ dysfunction caused by microbial invasion that disrupts the immunological response [1, 2]. The sepsis cytokine storm causes an exaggerated inflammatory storm, which often results in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [3, 4]. More than 3 million individuals globally are diagnosed with ARDS each year, accounting for 10% of hospital critical care unit admissions [5]. Despite advances in medical technology, such as broad-spectrum antibiotics, mechanical ventilation, continuous renal replacement, and extracorporeal membrane lung oxygenation, ARDS patient mortality remains significant at ~40% [6].
CD8+ T cells are important for protective immunity against intracellular pathogens. Excessive amounts of antigen and/or inflammatory signals often lead to the gradual deterioration of CD8+ T-cell function, a state called “exhaustion”. In our previous study, we discovered CD8+ T-cell exhaustion in the blood of patients with ARDS [7, 8]. The number of CD8+ T cells and coinhibitory receptors (PD-1 and Tim-3) were promising independent prognostic markers of sepsis-induced ALI [8]. Transcriptome analysis results suggested that the HSP90AA1 gene was underexpressed in sepsis-associated ARDS [7]. However, it was unclear whether the changes in CD8+ T cells were related to HSP90α, which was encoded by the HSP90AA1.
HSP90α is a widely expressed and conserved molecule located in the cytoplasm, mitochondria, and endoplasmic reticulum of eukaryotic cells [9, 10]. It mediates the maturation and stabilization of intracellular proteins, facilitates the folding and remodeling of a variety of proteins, and is a key regulatory factor that affects cell growth, differentiation, and the apoptosis pathway [9, 11]. Hundreds of proteins depend on HSP90α chaperone activity, including kinases and transcription factors, and so HSP90α plays an important role in inflammation and cell growth [12,13,14,15]. Therefore, we hypothesized that HSP90α was involved in exhaustion and functional change in CD8+ T cells in sepsis-related ARDS.
In this study, we used a lipopolysaccharide (LPS)-induced ALI mouse model to observe the changes in phenotype and function of CD8+ T cells. We investigated the effect of HSP90α on CD8+ T-cell exhaustion. At the same time, we explored the interaction and possible regulatory mechanism of the HSP90α/STAT1/TOX pathway during CD8+ T-cell exhaustion. This study helps to clarify the exhaustion transition and potential mechanisms in CD8+ T cells with the progression of lung injury. Understanding the mechanism of CD8+ T-cell exhaustion is expected to provide new ideas for preventing and treating sepsis-related ARDS.
Results
Inhibition of HSP90α exacerbated LPS-induced lung injury
A sepsis-related ALI model was established by endotracheal infusion of LPS. The results of gross lung tissue specimens and HE staining are shown in Fig. 1b and c. In the control group, the appearance of the lung lobes was normal, and there was no obvious swelling or hemorrhage. Under a light microscope, HE staining showed that the trachea and alveolar structures were complete, the interstitium of the lung was evenly distributed, and no obvious bleeding or inflammatory cell accumulation was observed in the alveoli or interstitium. However, significant swelling, exudation, and diffuse bleeding were observed in gross lung tissue samples 48 h after ALI modeling. HE staining showed that the normal structure of alveolar tissue was destroyed at this point, accompanied by diffuse capillary hemorrhage and massive inflammatory cell infiltration in the alveoli and interstitial spaces of the lungs. In ALI mice without any intervention, the mice that were still alive after 1 week had reduced swelling in the lung tissue, less exudation, and less bleeding. There was less destruction of the alveolar wall as shown by HE staining, inflammatory cell infiltration in lung tissue was reduced, and intra-alveolar and interstitial hemorrhage was reduced compared with those at 48 h. Swelling and hemorrhage of the lung tissues were significantly reduced in mice that were still alive after two weeks. Additionally, inflammatory cell infiltration in lung tissues was further reduced, as shown by HE staining, hemorrhage in the alveoli and interstitium was absorbed, and the alveolar structures were gradually restored.
a Schematic illustration of the experiments carried out in the ALI/17-AAG intervention groups. b Changes in gross lung tissues in mice treated with LPS for different times (48 h, 1 week, 2 weeks), the 17-AAG group, and the control group. c Microscopic lung tissue changes after HE staining. Inflammatory infiltration in lung tissue, alveolar epithelial hyperplasia, and local tissue bleeding are shown in red, green, and yellow. d Shows the statistical results obtained by the HE staining score in each group. e Statistical analysis of the ratio of wet weight to dry weight of lung tissue in each group. f The survival rate of mice injected with 17-AAG was lower than that of untreated ALI mice (P < 0.05). g and h Cytokine expression in serum and alveolar lavage fluid at different time points after ALI. *P < 0.05, **P < 0.01.
In the HSP90α inhibition group, we performed intraperitoneal injections of 17-AAG after LPS-induced ALI. After one week, we observed that lung tissue swelling appeared more obvious in the HSP90α-inhibited group than in the untreated group. Although the number of inflammatory cells in the lung tissue was reduced, the damage to the alveolar structure, alveolar exudation, and local bleeding remained severe, and the lung tissue injury score was higher than that of untreated ALI mice (Fig. 1b–e).
Inhibition of HSP90α reduced inflammatory responses after ALI
IFN-γ, TNF-α, and IL-2 in serum and alveolar lavage fluid were detected at different time points by ELISA to examine the systemic and intrapulmonary inflammatory responses after ALI. As shown in Fig. 1g, h, the inflammatory response in blood and alveolar lavage fluid peaked 48 h after LPS injection, as shown by the production of IFN-γ, TNF-α, and IL-2. These cytokines decreased after 1 week but were still significantly higher than those in the control group. IFN-γ, TNF-α, and IL-2 levels in alveolar lavage fluid and TNF-α levels in serum declined after two weeks, and IL-2 in alveolar lavage fluid and TNF-α in serum approached control values. Compared with those of untreated ALI mice, the expression of IFN-γ, TNF-α, and IL-2 in serum and IFN-γ in alveolar lavage fluid was further decreased in the 17-AAG group, suggesting that the inhibition of HSP90α expression in vivo may weaken systemic and lung inflammatory responses.
Inhibiting HSP90α reduced CD8+ T-cell infiltration during ALI
The lung tissues of mice in each group were stained for CD8 and HSP90α (Fig. 2). Inflammatory cells, including CD8+ T cells, rapidly increased in lung tissue at 48 h after modeling. One week later, inflammation was decreased, and the infiltration of CD8+ T cells also decreased. HSP90α was highly expressed in inflammatory cells, including CD8+ T cells, in lung tissues at 48 h after modeling. Compared to that at 48 h, the expression of HSP90α was dramatically downregulated in lung tissue after 1 week and further decreased after 2 weeks. HSP90α was scarcely expressed in the lung tissues of mice in the 17-AAG intervention group, and CD8+ T cells in this group were also dramatically decreased (Fig. 2).
HSP90α is shown in green, CD8 is in red, and the nucleus is in blue. a Representative immunofluorescence staining of CD8/HSP90α in lung tissue in the 48 h, 1 week, 1 week + 17-AAG, 2 weeks, and control groups after ALI induction. b Quantitative analysis of the mean fluorescence intensity of HSP90α in the lungs in each group of mice. c is the statistical result of the percentage of CD8-positive cells in the lungs in each group of mice. *P < 0.05, **P < 0.01.
Inhibition of HSP90α weakened the proliferation of CD8+ T cells
In this study, CD8+ T cells from each group of mice were isolated and cultured in vitro to examine their proliferative activity (Fig. 3e). These results suggested that CD8+ T-cell proliferation was most active in the acute phase of LPS-induced ALI (48 h) but decreased after 1 week. By 2 weeks after modeling, the proliferative capacity of murine CD8+ T cells was partially restored, but the OD values were not significantly different compared to those at 1 week. However, one week after intraperitoneal injection of 17-AAG, the proliferative activity of CD8+ T cells was worse than that in the untreated ALI group.
a Schematic illustration of the experiments carried out on CD8+ T cells isolated from the ALI/17-AAG intervention groups. b and c Typical flow patterns of PD-1 and Tim-3 in CD8+ T cells from mice at 48 h, 1 week, and 2 weeks following intratracheal injection of LPS, as well as in the 17-AAG-treated and control groups. d The statistical analysis of the expression of the two negative costimulatory molecules. e The proliferation of CD8+ T cells in each group of mice. f Representative flow cytograms showing the expression of TNF-α and IFN-γ in CD8+ T cells in each group. g Statistical analysis of TNF-α and IFN-γ in CD8+ T cells in each group. *P < 0.05, **P < 0.01.
Inhibition of HSP90α promoted CD8+ T-cell exhaustion
The expression of negative regulatory molecules (PD-1, Tim-3) in murine CD8+ T cells was analyzed by flow cytometry. As shown in Fig. 3b and c, in response to continuous inflammatory stimulation, CD8+ T cells overexpressed the negative costimulatory molecules PD-1 and Tim-3 after one week of ALI. However, after 2 weeks of modeling, the expression of exhaustion molecules in CD8+ T cells decreased with the alleviation of inflammation. The maximum number of CD8+ T cells synthesizing TNF-α and IFN-γ was observed after 48 h, which was considerably reduced after 1 week, indicating that the capacity to produce cytokines was weakened after 1 week. With the recovery of the disease and the reduction in inflammation after 2 weeks, the expression of PD-1 and Tim-3 on the surface of CD8+ T cells was reduced, but the level was still higher than that in the control group, and the ability of these cells to synthesize cytokines also recovered (Fig. 2d, f, g).
When mice were intraperitoneally injected with 17-AAG one week after the LPS-induced ALI model was established, CD8+ T cells showed increased expression of negative costimulatory molecules (PD-1, Tim-3), and their capacity to secrete the cytokines TNF-α and IFN-γ was further diminished in comparison to those in the untreated group (Fig. 3b–d, f, g).
Inhibition of HSP90α worsened the prognosis of ALI mice
Survival analysis of the untreated group and 17-AAG-treated ALI group suggested that inhibiting HSP90α expression decreased the survival rate of ALI mice, and the prognosis of mice in this group was worse (P < 0.05) (Fig. 1f).
HSP90α/STAT1/TOX was involved in the phenotypic changes of CD8+ T cells in LPS-induced ALI
RT-PCR was used to analyze the mRNA expression of HSP90α, STAT1, STAT3, STAT5, TOX, and NFATc1 in the CD8+ T cells of mice at 48 h, 1 week and 2 weeks after LPS induction of ALI and the control group. The results are presented in Fig. 4a. HSP90α, STAT1, STAT3, and STAT5 mRNA peaked 48 h after ALI, but the exhaustion-related transcription factors TOX and NFATc1 were expressed at low levels. After 1 week of LPS-induced ALI, the expression of exhaustion-related transcription factors TOX and NFATc1 increased. However, STAT1 and HSP90α were considerably decreased compared to 48 h. STAT3 and STAT5 did not change significantly. Therefore, we hypothesized that HSP90α was involved in the regulation of CD8+ T-cell exhaustion through the regulation of STAT1.
a Expression of transcription factors associated with CD8+ T-cell exhaustion after ALI induction by LPS. b Schematic illustration of the experiments carried out on CD8+ T cells isolated from the ALI/17-AAG intervention groups. c Representative Western blot results of HSP90α, STAT1, and TOX in different ALI groups. d Quantitative analysis of HSP90α, STAT1, and TOX. e Representative Western blot results of NFATc1, HSP90α, p-STAT1, STAT1, and TOX in ALI-1 week and 17-AAG intervention groups. f Quantitative analysis of NFATc1, HSP90α, p-STAT1, STAT1, and TOX.
HSP90α and STAT1 inhibited CD8+ T-cell exhaustion
We further verified the HSP90α/STAT1/TOX signaling pathway by Western blotting. As shown in Fig. 4c and d, like mRNA expression, the protein expression of HSP90α and STAT1 peaked at 48 h, and TOX peaked one week later. However, the expression of HSP90α and STAT1 was downregulated at one week. It was discovered that the protein expression of HSP90α and STAT1 was negatively correlated with the expression of TOX, a crucial transcriptional regulator of CD8+ T-cell exhaustion, which was consistent with the analysis of negative costimulatory molecules and cytokines in earlier experiments [16]. As shown in Fig. 4e and f, inhibiting HSP90α with 17-AAG reduced STAT1 and increased TOX but did not affect NFATc1.
These findings suggested that the exhaustion phenotype of CD8+ T cells may be adversely linked with the expression of HSP90α and STAT1. Inhibiting HSP90α expression in ALI may increase the expression of exhaustion markers in CD8+ T cells and decrease their capacity for proliferation and cytokine release.
Stimulating or inhibiting HSP90α induced phenotypic alterations of CD8+ T cells
In the previous study, the proliferation and function of CD8+ T cells in mice were the weakest after 1 week of ALI. To further verify the effect and regulatory mechanism of HSP90α, CD8+ T cells were isolated and cultured after 1 week of ALI modeling. After the addition of an HSP90α stimulator (terazosin) and suppressor (17-AAG), CD8+ T-cell proliferation and the expression of negative stimulatory molecules (PD-1, Tim-3) and cytokines (IFN-γ, TNF-α) were examined. As shown in Fig. 5b–g, after the HSP90α agonist was added to CD8+ T cells in vitro, cell proliferation was enhanced, the expression of PD-1 and Tim-3 was decreased, and the expression of cytokines (TNF-α and IFN-γ) was increased. In contrast, CD8+ T cells exposed to HSP90α inhibitors showed reduced viability, increased production of negative costimulatory markers, and reduced cytokine production. These results suggested that HSP90α may play a role in controlling CD8+ T-cell phenotypic transformation.
a Schematic illustration of drug stimulation/inhibition of CD8+ T cells. b and c Representative flow plots showing PD-1 and Tim-3 in CD8+ T cells after the addition of Terazosin/17-AAG. d Representative flow charts of TNF-α and IFN-γ synthesis by CD8+ T cells after the addition of Terazosin/17-AAG. e Statistical analysis of PD-1 and Tim-3 in CD8+ T cells. f Comparison of the proliferation rate of CD8+ T cells after the stimulation/inhibition of HSP90α. g Statistical analysis of TNF-α and IFN-γ expressed by CD8+ T cells. h Typical bands of HSP90α and STAT1 after adding terazosin/17-AAG to CD8+ T cells. i Results of the quantitative analysis of HSP90α and STAT1.
Agonism or inhibition of HSP90α influenced the expression of STAT1
The exhaustion phenotype of CD8+ T cells was most obvious at 1 week after LPS-induced ALI, and the expression of HSP90α and STAT1 was significantly downregulated at this time. Therefore, we analyzed the changes in STAT1 expression in CD8+ T cells isolated from the ALI-1-week group. After adding HSP90α agonists/inhibitors in vitro, the Western blot results confirmed that the change in STAT1 was consistent with that in HSP90α (Fig. 5h and i). Based on these results, we hypothesized that HSP90α could regulate the downstream signaling of CD8+ T cells by regulating STAT1 expression.
HSP90α and STAT1 synergistically orchestrated CD8+ T-cell exhaustion
To further verify the downstream regulatory mechanism of HSP90α, we next performed siRNA interference on the transcription factor STAT1. The Western blot results indicated that the expression of HSP90α was decreased after STAT1 interference, indicating that the expression of HSP90α was dependent on STAT1 (Fig. 6g, h). Furthermore, with the decrease in the expression of STAT1 and HSP90α, the proliferation of CD8+ T cells decreased (Fig. 6k), the expression of negative costimulatory molecules increased (Fig. 6b–d), and the ability of these cells to synthesize cytokines decreased (Fig. 6e and f). Therefore, these results suggested that HSP90α regulation of CD8+ T-cell exhaustion was dependent on STAT1 and that these two proteins play a synergistic role in CD8+ T-cell exhaustion.
a Schematic illustration of STAT1 interference in CD8+ T cells. b and d Representative flow plots showing PD-1 and Tim-3 expressed by CD8+ T cells after STAT1 interference. c Statistical analysis of PD-1 and Tim-3 expressed in CD8+ T cells. e Representative flow charts of TNF-α and IFN-γ synthesis by CD8+ T cells after STAT1 interference. f Statistical analysis of TNF-α and IFN-γ expressed by CD8+ T cells. g Representative bands showing HSP90α, STAT1, and p-STAT1 expression in control and STAT1 siRNA-transfected CD8+ T cells. h Statistical analysis of HSP90α, STAT1, and p-STAT1. i The interaction of CD8+ T cell HSP90α with STAT1 and TOX. j The interaction of STAT1 with TOX. k Comparison of the proliferation rate of CD8+ T cells after STAT1 interference.
HSP90α modulated TOX directly or indirectly through STAT1
Finally, to further examine the proteins that interact with HSP90α in CD8+ T cells, we used Co-IP and Western blotting to precipitate HSP90α and detect proteins that interact with HSP90α. The expression of STAT1, p-STAT1, and TOX was observed in anti-HSP90α immunoprecipitation, demonstrating that HSP90α could bind to STAT1 and TOX in CD8+ T cells (Fig. 6i).
In CD8+ T cells STAT1 can also bind TOX directly (Fig. 6j). The expression of TOX was increased after STAT1 was disrupted, indicating that STAT1 was involved in the regulation of TOX in CD8+ T cells (Fig. 6i). HSP90α binding to TOX was decreased after STAT1 was knocked down. These results suggest that, in addition to the direct binding of HSP90α to TOX to govern the phenotypic transformation of CD8+ T cells, HSP90α may regulate TOX protein indirectly via STAT1.
Discussion
Immune defense against intracellular infections depends on immune cells. In response to intense and persistent inflammation and antigenic signaling, lymphocytes always gradually differentiate into an exhausted phenotype [15, 17, 18]. In this study, the ALI model was constructed by injecting LPS into the trachea of mice. Pathological examination of lung tissue indicated that in the acute stage of LPS-induced lung injury, a large number of inflammatory cells accumulated in the lung tissue, and cytokines were significantly increased in serum and alveolar lavage fluid. However, with time and the self-repair of the immune system, immune cells gradually decreased in the lung tissue of surviving mice in the absence of any therapeutic intervention. On the one hand, it is possible that as the disease improves, the inflammation in lung tissue subsides, and immune cells are redistributed in vivo. On the other hand, the proliferation and function of immune cells may be weakened by the continuous stimulation of antigens/inflammation, leading to a decrease in the accumulation of inflammatory cells in the lung.
CD8+ T cells play an essential role in immune monitoring and the adaptive immune response against microbial infection [19]. When T-cell receptors are triggered by external antigens or pathogens, these cells quickly activate and proliferate. CD8+ T cells respond to antigens and pathogens by secreting immunoregulatory cytokines and chemokines or by direct killing [19].
Previous studies revealed that when pathogenic germs were not eliminated quickly, and antigenic and inflammatory stimuli remained, T cells developed an exhaustion phenotype [15, S1.
Western blot assay
CD8+ T cells were lysed on ice with Radio immunoprecipitation assay (RIPA) buffer (Beyotime, P0013C) containing protease inhibitor (Beyotime, P1005) and phosphatase inhibitor (Beyotime, P1050) for protein collection. After centrifugation at 14,000×g for 10 min at 4 °C, the supernatants were collected. Then, the protein concentration was quantified using the BCA Protein Quantitative Analysis Kit (Beyotime, P0009). Appropriate amounts of proteins were added to 7.5% sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by migration and transferred onto polyvinylidene difluoride membranes. After washing, the membranes were blocked with Quickblock™ blocking buffer (Beyotime, P0231) for 30 min and incubated with specific primary antibodies against β-actin (Abcam, ab8226), HSP90α (Abcam, ab2928), TOX (Abcam, ab155768), STAT1 (Abcam, ab239360), p-STAT1 (Abcam, ab109461) and NFATc1 (Abcam, ab2796) at 4 °C overnight. The following day, the membranes were washed in TBST and incubated with the corresponding second antibody for 1 h at room temperature. Immunoreactive bands were visualized by chemiluminescence using an ECL Kit (Beyotime, P0018FS). Protein quantification was performed using ImageJ software (https://imagej.net/).
Co-immunoprecipitation (Co-IP)
CD8+ T cells were lyzed at 4 °C for 30 min in ice‐cold RIPA buffer. Supernatants were separated by centrifugation (14,000×g 10 min at 4 °C). Cell lysates were incubated with anti‐HSP90α (Abcam, ab2928), anti‐STAT1 (Abcam, ab239360), or the control IgG antibody (Beyotime, P2179M) for 16 h at 4 °C followed by a 2 h incubation with Protein A/G beads (Beyotime, P2179M) at 4 °C. After three washes with IP lysis buffer, protein samples were collected by boiling in 1 × SDS loading buffer for 10 min. Samples were separated using SDS–PAGE and further analyzed by performing immunoblotting. Immunoprecipitation with mouse IgG was taken as the negative control.
Statistical analysis
Data were organized and analyzed using GraphPad Prism (version 7.0, CA, USA) and SPSS software (version 21, IL, USA). The Shapiro–Wilk test was used to check the normality and homogeneity of variance of all data. Differences between the two groups were analyzed by the two-tailed t-test. Multiple comparisons were performed by one-way analysis of variance (ANOVA) followed by the Bonferroni post hoc test, respectively. The survival curve was plotted using the Kaplan–Meier method. All data were expressed as mean ± standard error, and p < 0.05 was considered statistically significant. Each independent experiment was repeated at least 3 times.
Data availability
Data described in this manuscript will be freely available upon request to any researcher wishing to use them for non-commercial purposes.
Materials availability
Materials described in this manuscript will be freely available upon request to any researcher wishing to use them for non-commercial purposes.
References
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.
Yin J, Chen Y, Huang JL, Yan L, Kuang ZS, Xue MM, et al. Prognosis-related classification and dynamic monitoring of immune status in patients with sepsis: a prospective observational study. World J Emerg Med. 2021;12:185–91.
Li W, Li D, Chen Y, Abudou H, Wang H, Cai J, et al. Classic signaling pathways in alveolar injury and repair involved in sepsis-induced ali/ards: new research progress and prospect. Dis Markers. 2022;2022:6362344.
Dvorščak MB, Lupis T, Adanić M, Aarić JP. Acute respiratory distress syndrome and other respiratory disorders in sepsis. Acta Med Croat. 2015;69:167–75.
Abe T, Madotto F, Pham T, Nagata I, Uchida M, Tamiya N, et al. Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries. Crit Care. 2018;22:195.
Pais FM, Sinha P, Liu KD, Matthay MA. Influence of clinical factors and exclusion criteria on mortality in ards observational studies and randomized controlled trials. Respir Care. 2018;63:1060–9.
Yan L, Tong CY. Analysis of blood immune cell and gene microarray data of patients with sepsis related acute respiratory distress syndrome based on GEO database. Fudan Univ J Med Sci, 2023;50:509–16, 525.
Yan L, Chen Y, Han Y, Tong C. Role of CD8(+) T cell exhaustion in the progression and prognosis of acute respiratory distress syndrome induced by sepsis: a prospective observational study. BMC Emerg Med. 2022;22:182.
Yadav M, Singh AK, Kumar A, Thareja S, Kumar P. An insight to heat shock protein 90: a remedy for multiple problems. Curr Pharm Des. 2022;28:2664–76.
Sima S, Richter K. Regulation of the HSP90 system. Biochim Biophys Acta Mol Cell Res. 2018;1865:889–97.
Dernovšek J, Tomašič T. Following the design path of isoform-selective HSP90 inhibitors: small differences, great opportunities. Pharm Ther. 2023;245:108396.
Costa T, Raghavendra NM, Penido C. Natural heat shock protein 90 inhibitors in cancer and inflammation. Eur J Med Chem. 2020;189:112063.
Bae J, Munshi A, Li C, Samur M, Prabhala R, Mitsiades C, et al. Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells. J Immunol. 2013;190:1360–71.
Albakova Z, Mangasarova Y, Sapozhnikov A. Impaired heat shock protein expression in activated T cells in B-cell lymphoma. Biomedicines. 2022;10:2747.
Liu K, Huang J, Liu J, Li C, Kroemer G, Tang D, et al. HSP90 mediates ifnγ-induced adaptive resistance to anti-pd-1 immunotherapy. Cancer Res. 2022;82:2003–18.
Cheng Y, Shao Z, Chen L, Zheng Q, Zhang Q, Ding W, et al. Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8(+) T cell exhaustion. Immunol Lett. 2021;229:1–7.
Roe K. A role for T-cell exhaustion in long COVID-19 and severe outcomes for several categories of COVID-19 patients. J Neurosci Res. 2021;99:2367–76.
Mclane LM, Abdel-Hakeem MS, Wherry EJ. Cd8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 2019;37:457–95.
Heidarian M, Griffith TS, Badovinac VP. Sepsis-induced changes in differentiation, maintenance, and function of memory CD8 T cell subsets. Front Immunol. 2023;14:1130009.
Liu Q, Xue M, Song Q, **e J, Yang Y, Liu S. Expression of pd-1 on memory T lymphocytes predicts 28-day mortality of patients with sepsis: a prospective observational study. J Inflamm Res. 2022;15:5043–52.
Danahy DB, Strother RK, Badovinac VP, Griffith TS. Clinical and experimental sepsis impairs CD8 T-cell-mediated immunity. Crit Rev Immunol. 2016;36:57–74.
Hashimoto M, Kamphorst AO, Im SJ, Kissick HT, Pillai RN, Ramalingam SS, et al. Cd8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev Med. 2018;69:301–18.
Vanders RL, Murphy VE, Gibson PG, Hansbro PM, Wark PA. Cd8 T cells and dendritic cells: key players in the attenuated maternal immune response to influenza infection. J Reprod Immunol. 2015;107:1–9.
Sen DR, Kaminski J, Barnitz RA, Kurachi M, Gerdemann U, Yates KB, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165–9.
Fitrolaki MD, Dimitriou H, Venihaki M, Katrinaki M, Ilia S, Briassoulis G. Increased extracellular heat shock protein 90α in severe sepsis and sirs associated with multiple organ failure and related to acute inflammatory-metabolic stress response in children. Medicine (Baltimore). 2016;95:e4651.
Scarneo SA, Smith AP, Favret J, O’Connell R, Pickeral J, Yang KW, et al. Expression of membrane HSP90 is a molecular signature of T cell activation. Sci Rep. 2022;12:18091.
Scott AC, Dündar F, Zumbo P, Chandran SS, Klebanoff CA, Shakiba M, et al. Tox is a critical regulator of tumour-specific T cell differentiation. Nature. 2019;571:270–4.
Seo H, Chen J, González-Avalos E, Samaniego-Castruita D, Das A, Wang YH, et al. Tox and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion. Proc Natl Acad Sci USA. 2019;116:12410–5.
Kurachi M. Cd8(+) T cell exhaustion. Semin Immunopathol. 2019;41:327–37.
Wickramaratne A, Wickner S. Diptoindonesin G, a new HSP90 drug. J Biol Chem. 2023;299:102826.
Talaei S, Mellatyar H, Asadi A, Akbarzadeh A, Sheervalilou R, Zarghami N. Spotlight on 17-AAG as an HSP90 inhibitor for molecular targeted cancer treatment. Chem Biol Drug Des. 2019;93:760–86.
Chen X, Zhao C, Li X, Wang T, Li Y, Cao C, et al. Terazosin activates PGK1 and HSP90 to promote stress resistance. Nat Chem Biol. 2015;11:19–25.
Belk JA, Daniel B, Satpathy AT. Epigenetic regulation of T cell exhaustion. Nat Immunol. 2022;23:848–60.
Pichler AC, Cannons JL, Schwartzberg PL. The road less taken: less appreciated pathways for manipulating CD8(+) T cell exhaustion. Front Immunol. 2022;13:926714.
Alfei F, Kanev K, Hofmann M, Wu M, Ghoneim HE, Roelli P, et al. Tox reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature. 2019;571:265–9.
Liu S, Yang Y, Zeng L, Wang L, He C, Chen Z, et al. Tox promotes follicular helper T cell differentiation in patients with primary Sjögren’s syndrome. Rheumatology (Oxford). 2023;62:946–57.
Ryan N, Anderson K, Volpedo G, Hamza O, Varikuti S, Satoskar AR, et al. STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma. Int J Cancer. 2020;146:1717–29.
Friedrich J, Heim L, Trufa DI, Sirbu H, Rieker RJ, Chiriac MT, et al. STAT1 deficiency supports PD-1/PD-L1 signaling resulting in dysfunctional TNFα mediated immune responses in a model of NSCLC. Oncotarget. 2018;9:37157–72.
He R, Liu B, **ong R, Geng B, Meng H, Lin W, et al. Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury. Cell Death Discov. 2022;8:43.
Chiu KH, Lee WL, Chang CC, Chen SC, Chang YC, Ho MN, et al. A label-free differential proteomic analysis of mouse bronchoalveolar lavage fluid exposed to ultrafine carbon black. Anal Chim Acta. 2010;673:160–6.
Acknowledgements
The study was conducted thanks to the helpful contributions of all staff from the experimental research center of Zhongshan Hospital affiliated with Fudan University.
Funding
This study was funded by grants from the National Key Research and Development Program of China (2021YFC2501800), the National Natural Science Foundation of China (82102255), and the Science and Technology of Shanghai Committee Program (21MC1930400).
Author information
Authors and Affiliations
Contributions
Chaoyang Tong and Yi Han designed the study. Lei Yan and Yumei Chen performed the research and collected the data. Lei Yan and Yilin Yang analyzed the data and wrote the manuscript. All authors read and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yan, L., Chen, Y., Yang, Y. et al. Heat shock protein 90α reduces CD8+ T cell exhaustion in acute lung injury induced by lipopolysaccharide. Cell Death Discov. 10, 283 (2024). https://doi.org/10.1038/s41420-024-02046-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41420-024-02046-8
- Springer Nature Limited